MedPath

Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant

Not Applicable
Completed
Conditions
Implant Site Reaction
Interventions
Other: sandblasted large acid itched coated titanium implant
Other: nano-hydroxy apatite coated titanium implants
Registration Number
NCT05936775
Lead Sponsor
October University for Modern Sciences and Arts
Brief Summary

the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla. 30 patients will be included in this trial divided into two groups, control and intervention. Primary and secondary implant stability will be measured

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patients with missing at least one maxillary posterior tooth
  2. Patients free from any systemic disease
  3. Patients who approve to be included in the trial and sign the informed consent
  4. Patients with no intra-bony defect.
  5. Adults aged 18 years old and above
Exclusion Criteria
  1. Patients who are allergic to titanium
  2. Heavy smoker patient
  3. Patients receiving chemotherapy or radiotherapy
  4. Patients who refused to be included in the trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SLA armsandblasted large acid itched coated titanium implantin this group patients will receive sandblasted large thread acid etched titanium implants
Nano-hydroxy apatite armnano-hydroxy apatite coated titanium implantsin this groups patients will receive nano-hydroxy apatite coated titanium implants
Primary Outcome Measures
NameTimeMethod
Implant stability12 weeks post-operative

implant stability will be measured by radiofrequency analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

October University for Modern Sciences and Arts faulty of Dentistry

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath